Pro-inflammatory cytokines and extracellular matrix components – indirect modulation

The term Pro-inflammatory cytokines and extracellular matrix components – indirect modulation refers to a broad therapeutic strategy or pharmacological effect rather than a single discrete molecular target. It encompasses the regulation of secreted signaling proteins, such as Tumor Necrosis Factor (TNF) and various Interleukins, alongside structural components like collagen and fibronectin, by targeting upstream regulatory nodes (PubMed: 30271547). This approach is essential in treating chronic inflammatory and fibrotic disorders where dysregulated signaling leads to persistent tissue destruction and pathological scarring (PubMed: 28473537). For instance, Janus kinase (JAK) inhibitors act as indirect modulators by blocking the intracellular signaling required for the expression of multiple pro-inflammatory genes (StatPearls: NBK544301). Similarly, anti-fibrotic agents may target tyrosine kinase receptors to indirectly reduce the activation of myofibroblasts responsible for excessive matrix deposition (PubMed: 25170800). Because this entry describes a multi-faceted biological process involving numerous proteins, it is classified as a functional description of drug action rather than a specific protein or receptor target.

Other names

Indirect modulation of inflammatory mediatorsRegulation of ECM and cytokinesDownstream signaling modulationIndirect cytokine suppression

Indirect modulation occurs through the inhibition of upstream signaling pathways (such as JAK/STAT, MAPK, or TGF-beta signaling) or transcriptional regulators that control the synthesis, secretion, and degradation of cytokines and extracellular matrix proteins.